In today's story: how PharmEasy's parent is buying out a ₹347.5 crore stake without spending a single rupee, and what it could mean for the IPO.
Imagine you want to buy your friend's share in a business you both run. But you don't want to empty your bank account. So you tell your friend, "Instead of cash, take a slice of my bigger business."
That's pretty much what API Holdings, the company behind PharmEasy, is doing right now. And if you hold API shares, you get a vote on it.
Akna Medical is a subsidiary of API Holdings that you've probably never heard of. It doesn't sell medicines to you and me through an app. It does wholesale trading of medicines.
And not just any medicines. Akna deals in specialised segments like critical care, anaesthesia, cardiac, oncology, obstetrics and gynaecology, IVF, ophthalmology, pulmonology and nephrology, among others.
In simple words, Akna runs warehouses, stocks these drugs and sells them in bulk. It's the quiet, behind-the-scenes plumbing of the pharma supply chain.
Right now, API Holdings owns 68.67% of Akna. The remaining 31.33% sits with Lightrock Growth Fund, a global investment fund.
API now wants the whole thing. So it's buying Lightrock's entire 31.33% stake, which works out to 10,50,376 Akna shares. Once that's done, Akna becomes a 100% subsidiary of API.
Here's the twist. API isn't paying cash. Instead, it will hand Lightrock 53.38 crore brand-new API shares called CCPS Series C, priced at ₹6.51 each. Multiply the two and you get roughly ₹347.5 crore.
One quick clarification, because it's easy to mix up. ₹6.51 is the price of the new API shares Lightrock receives, not the price of an Akna share. Work it backwards and Lightrock's stake is valued at about ₹3,308 per Akna share, which puts all of Akna at roughly ₹1,100 crore.
Before | After | |
|---|---|---|
| API's stake in Akna | 68.67% | 100% |
| Lightrock's stake in Akna | 31.33% | 0% |
| Lightrock's holding in API | — | 53.38 crore CCPS C |
CCPS stands for Compulsorily Convertible Preference Shares. Sounds like a mouthful, so let's break it down.
Preference means these shares get paid before ordinary shareholders if the company ever shuts down and sells off its assets. Compulsorily convertible means they can't stay preference shares forever. At some point, they must turn into regular equity shares.
Here's how API's new CCPS C works:
Conversion: each CCPS C becomes 1 API equity share. Lightrock can convert anytime. If it doesn't, conversion happens automatically at an IPO, or at the latest by April 1, 2046.
Dividend: 0.0001% a year. That's practically zero. Nobody is in this for the dividend.
Voting: CCPS C votes as if it has already been converted into equity.
Pecking order: if things go south, CCPS A and B holders get paid first, then CCPS C, and only then regular equity shareholders.
Think of CCPS as equity with a seatbelt. It behaves like equity on the way up, but gets a little extra protection on the way down.
The official reason is simple: cash. A share swap lets API buy the stake without any immediate cash outflow, so it can keep its money for running the business.
But we think there's a bigger picture here.
When a company prepares for an IPO, investors want a clean, simple structure. Subsidiaries with outside minority shareholders make the story messy. Who owns what? Whose profits belong to whom? Every minority stake is one more footnote in the prospectus.
Buying out Lightrock tidies that up. Akna becomes fully API's, and Akna's numbers flow neatly into API's books. On top of that, the new CCPS C converts automatically at an IPO. So in our view, API looks like it's consolidating its businesses under one roof before going public.
To be clear, that last bit is our reading of the move. The notice itself doesn't mention any IPO timeline.
If you hold API Holdings shares, two things matter.
1. A small dilution. API's fully diluted share count goes up from about 1,804 crore shares to about 1,857 crore shares. That's roughly 2.87% dilution for every existing shareholder. For example, the Indian public's combined holding slips from 26.02% to 25.28%.
2. A new shareholder ahead of you in line. If the company is ever liquidated, CCPS C holders get paid before regular equity holders. In a healthy company that's mostly theoretical, but it's worth knowing.
In return, API gets full ownership of a specialised medicine wholesaler without touching its cash.
This isn't a meeting. It's a postal ballot done entirely online. It needs a special resolution, which means at least 75% of the votes cast must be in favour.
Details | |
|---|---|
| Who can vote | Anyone holding API equity, CCPS A or CCPS B on October 9, 2026 |
| Where | CDSL e-voting at evotingindia.com, or through your demat or broker login |
| EVSN for equity holders | 261014003 |
| Last date | November 15, 2026, 5:00 PM IST |
| Results | On or before November 22, 2026 |
API's board has recommended that shareholders vote in favour.
API is buying a ₹347.5 crore stake with paper instead of cash, tidying up its family tree, and maybe clearing the decks for a listing. Existing shareholders give up a little under 3% in return.
Whether that's a fair trade is your call. You've got until November 15 to make it.
For more such updates on unlisted shares, stay tuned to UnlistedZone.
Disclaimer: This article is for educational purposes only and is not investment advice. All figures are taken from API Holdings' Postal Ballot Notice dated October 16, 2026. Please do your own research or consult a financial advisor before making any decision.